6-Substituted derivatives of clavulanic acid
    1.
    发明授权
    6-Substituted derivatives of clavulanic acid 失效
    6-取代的克拉维酸的衍生物

    公开(公告)号:US4571392A

    公开(公告)日:1986-02-18

    申请号:US370081

    申请日:1982-04-20

    CPC分类号: C07D503/00

    摘要: The present invention provides the compounds of the formula (II): ##STR1## and salts and esters thereof wherein R.sub.1 is a hydrogen atom or an alkyl group of 1-4 carbon atoms and R.sub.2 is a hydrogen atom or an alkyl group of 1-4 carbon atoms or is joined to R.sub.1 to form part of a 5-, 6- or 7 membered carbocyclic ring. These compounds are .beta.-lactamase inhibitors able to enhance the effectiveness of pencillins and cephalosporins. Their preparation and compositions containing them are described.

    摘要翻译: 本发明提供了式(II)的化合物:其中R 1是氢原子或1-4个碳原子的烷基,R 2是氢原子或烷基 1-4个碳原子的烷基或与R1连接形成5-,6-或7-元碳环的一部分。 这些化合物是能够增强Pencillins和头孢菌素有效性的β-内酰胺酶抑制剂。 描述了它们的制备方法和含有它们的组合物。

    4-Haloalkylamino substituted chromanol useful as antihypertensive agent
    2.
    发明授权
    4-Haloalkylamino substituted chromanol useful as antihypertensive agent 失效
    4-卤代烷基氨基取代的色原烷醇可用作抗高血压药

    公开(公告)号:US4481213A

    公开(公告)日:1984-11-06

    申请号:US398553

    申请日:1982-07-15

    申请人: John M. Evans

    发明人: John M. Evans

    CPC分类号: C07D311/68

    摘要: A compound of the formula (I): ##STR1## and pharmaceutically acceptable salts thereof wherein R.sub.1 is hydrogen or C.sub.1-6 alkyl or an acyl group of 1 to 8 carbon atoms; n is 2, 3 or 4; X is halogen; and the OR.sub.1 and HN(CH.sub.2).sub.n X moieties are trans; has anti-hypertensive activity and a low level of cardiac side-effects.

    摘要翻译: 式(I)的化合物:其中R 1是氢或C 1-6烷基或具有1至8个碳原子的酰基; n为2,3或4; X是卤素; 并且OR 1和HN(CH 2)n X部分是反式; 具有抗高血压活性和低水平的心脏副作用。

    Treatment of diarrhoea with 2-aminoimidazoline derivatives
    4.
    发明授权
    Treatment of diarrhoea with 2-aminoimidazoline derivatives 失效
    用2-氨基咪唑啉衍生物治疗腹泻

    公开(公告)号:US4450170A

    公开(公告)日:1984-05-22

    申请号:US277034

    申请日:1981-06-24

    摘要: Compounds A - B - C wherein A is 2 imidazolinyl or N-alkyl derivative thereof, B is oxygen, sulphur, CR.sup.1 R.sup.2 wherein R.sup.1 and R.sup.2 are hydrogen or alkyl, or NR.sup.3 wherein R.sup.3 is hydrogen or alkyl, and C is a 5 - or 6 - membered carbo- or heterocyclic group having a nitrogen containing substituent and up to two other substituents, are useful in treatment of diarrhoea or scours. Certain compounds A - B - C are novel.

    摘要翻译: 化合物A-B-C其中A是2个咪唑啉基或其N-烷基衍生物,B是氧,硫,CR1R2,其中R1和R2是氢或烷基,或NR3,其中R3是氢或烷基,C是5-或 具有含氮取代基和至多两个其它取代基的6-元碳 - 杂环基可用于治疗腹泻或冲洗。 某些化合物A-B-C是新的。

    Penicillin derivatives
    7.
    发明授权
    Penicillin derivatives 失效
    青霉素衍生物

    公开(公告)号:US4416883A

    公开(公告)日:1983-11-22

    申请号:US277031

    申请日:1981-06-24

    申请人: Peter H. Bentley

    发明人: Peter H. Bentley

    CPC分类号: C07D499/00

    摘要: A compound of formula (I) or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof: ##STR1## wherein R is phenyl, 4-hydroxy phenyl, or a 5- or 6-membered heterocyclic ring containing up to three heteroatoms selected from oxygen, sulphur or nitrogen, optionally substituted with hydroxy, amino, halogen or C.sub.1-6 alkoxy;R.sup.1 represents hydrogen or C.sub.1-6 alkyl;R.sup.2 and R.sup.3 are the same or different and represent hydrogen, C.sub.1-6 alkyl, halogen, amino, hydroxy, or C.sub.1-6 alkoxy.Their preparation and use is described.

    摘要翻译: 式(I)化合物或其药学上可接受的盐或体内可水解的酯:其中R是苯基,4-羟基苯基或含有至多三个杂原子的5-或6-元杂环 选自氧,硫或氮,任选被羟基,氨基,卤素或C 1-6烷氧基取代; R1代表氢或C1-6烷基; R2和R3相同或不同,表示氢,C1-6烷基,卤素,氨基,羟基或C1-6烷氧基。 描述了它们的制备和使用。

    3-Oxo-6-oxa-2-azatricyclo 5.4.2. unadecene-4-carboxylate
    8.
    发明授权
    3-Oxo-6-oxa-2-azatricyclo 5.4.2. unadecene-4-carboxylate 失效
    3-氧代-6-氧杂-2-氮杂三环5.4.2。 十九碳烯-4-羧酸酯

    公开(公告)号:US4415584A

    公开(公告)日:1983-11-15

    申请号:US006436

    申请日:1979-01-25

    申请人: Eric Hunt

    发明人: Eric Hunt

    CPC分类号: C07D503/00

    摘要: Compounds of the formula (II): ##STR1## wherein R.sub.1 is hydrogen or alkyl of 1 to 4 carbon atoms, CO.sub.2 R.sub.2 is a carboxyl group, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable esterified carboxyl group, are useful for their .beta.-lactamase inhibitory activity and to synergize the antibacterial activity of penicillins and cephalosporin.

    摘要翻译: 式(II)的化合物:其中R 1为氢或1至4个碳原子的烷基,CO 2 R 2为羧基,其药学上可接受的盐或药学上可接受的酯化羧基,可用于它们 β-内酰胺酶抑制活性,并协同青霉素和头孢菌素的抗菌活性。

    Piperazine derivatives
    9.
    发明授权
    Piperazine derivatives 失效
    哌嗪衍生物

    公开(公告)号:US4405620A

    公开(公告)日:1983-09-20

    申请号:US227621

    申请日:1981-01-19

    摘要: Compounds of the formula (I), or pharmaceutically acceptable salts thereof ##STR1## wherein X is phenyl, optionally substituted by one halogen, C.sub.1-4 alkyl or C.sub.1-4 alkoxy; or pyridyl; R.sub.1 is hydrogen or C.sub.1-6 alkyl; and n is 1 to 6, pharmaceutical compositions containing them and a process for their preparation. These compounds are useful in the prophylaxis or treatment of diseases due to a histamine-mediated allergic response.

    摘要翻译: 式(I)化合物或其药学上可接受的盐其中X为苯基,任选被一个卤素,C 1-4烷基或C 1-4烷氧基取代; 或吡啶基; R1是氢或C1-6烷基; n为1〜6,含有它们的药物组合物及其制备方法。 这些化合物可用于预防或治疗由于组胺介导的过敏反应引起的疾病。

    Cephalosporin derivatives, and compositions containing them
    10.
    发明授权
    Cephalosporin derivatives, and compositions containing them 失效
    头孢菌素衍生物和含有它们的组合物

    公开(公告)号:US4394375A

    公开(公告)日:1983-07-19

    申请号:US271008

    申请日:1981-06-05

    CPC分类号: C07D505/00 A61K31/545

    摘要: A compound of formula (I) or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof: ##STR1## wherein R is phenyl, 4-hydroxyphenyl, or a 5- or 6-membered heterocyclic ring containing up to three heteroatoms selected from oxygen, sulphur or nitrogen, optionally substituted with hydroxy, amino, halogen or C.sub.1-6 alkoxy;R.sup.1 represents hydrogen or C.sub.1-6 alkyl;R.sup.2 and R.sup.3 are the same or different and represent hydrogen, C.sub.1-6 alkyl, halogen, amino, hydroxy, or C.sub.1-6 alkoxy;X represents oxygen or sulphur; andA represents hydrogen, pyridyl, acetoxy, carbamoyloxy or a heterocyclicthio group;Their preparation and use is described.

    摘要翻译: 式(I)化合物或其药学上可接受的盐或体内可水解的酯:其中R是苯基,4-羟基苯基或含有至多三个杂原子的5-或6-元杂环, 任选被羟基,氨基,卤素或C 1-6烷氧基取代的氧,硫或氮; R1代表氢或C1-6烷基; R2和R3相同或不同,表示氢,C1-6烷基,卤素,氨基,羟基或C1-6烷氧基; X表示氧或硫; A代表氢,吡啶基,乙酰氧基,氨基甲酰氧基或杂环硫基; 描述了它们的制备和使用。